^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    MSH6 rs3136228

    i
    Other names: MSH6, GTBP, MutS homolog 6
    Entrez ID:
    2956
    Related biomarkers:
    Expression
    Mutation
    CNA
    Others
    1year
    MSH3 and MSH6 gene polymorphisms: Association with lung cancer susceptibility and prognostic value in patients with NSCLC undergoing platinum-based chemotherapy. (ASCO 2023)
    The results of this cohort study suggest that MSH3 and MSH6 polymorphisms are involved in modulating the risk towards LC occurence. MSH6 polymorphism is also associated with higher mortality amongst patients treated with docetaxel-platinum chemotherapy.
    Clinical
    |
    MSH6 (MutS homolog 6) • MSH3 (MutS Homolog 3)
    |
    MSH6 rs3136228
    |
    docetaxel